[1
]
Affiliations of authors: Divisions of Medical Oncology and Hematology, Princess Margaret
Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (AJT,
MGM, FEV-B, PA, RL-A, JJK, IFT, EA); Department of Medical Oncology, Institute of
Oncology Ljubljana, Slovenia (BS); Medical Oncology University Hospital, Albacete,
Spain (AO); University of Alabama, Birmingham Comprehensive Cancer Center, Birmingham,
AL (GS); Department of Medical Oncology, Royal Melbourne Hospital, Melbourne, Australia
(BT).
[2
]
Affiliations of authors: Divisions of Medical Oncology and Hematology, Princess Margaret
Cancer Centre, Department of Medicine, University of Toronto, Toronto, Canada (AJT,
MGM, FEV-B, PA, RL-A, JJK, IFT, EA); Department of Medical Oncology, Institute of
Oncology Ljubljana, Slovenia (BS); Medical Oncology University Hospital, Albacete,
Spain (AO); University of Alabama, Birmingham Comprehensive Cancer Center, Birmingham,
AL (GS); Department of Medical Oncology, Royal Melbourne Hospital, Melbourne, Australia
(BT). eitan.amir@uhn.ca.